产品编号：B675705
产品规格：50mg
产品价格：面议
| 标准品编号: | B675705 |
| 名称: | (1R,2R)-Bortezomib |
| 别名: | B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; Bortezomib USP Related Compound A |
| 杂质: | Bortezomib USP Related Compound A |
| CAS号: | 1132709-15-9 |
| 分子式: | C₁₉H₂₅BN₄O₄ |
| 外观: | 白色固体 |
| 熔点: | >167ºC (dec.) |
| 分子量: | 384.24 |
| 储存: | -20°C Freezer, Under inert atmosphere |
| 溶解度: | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
| 类别: | Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway |
| 危险品信息: | Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |
| 参考文献 | |
